Clinical Trial

A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to characterize andexanet posology and interaction between andexanet and enoxaparin post infusion in healthy participants.
Protocol Amendment History 2 changes
critical Trial completed 2026-07-10
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-03
Trial Details
NCT Number NCT07312851
Lead Sponsor AstraZeneca
Collaborators: Parexel
Conditions Healthy Participants
Enrollment 191 participants
Start Date 2026-01-19
Primary Completion 2026-06-22 (estimated)
Study Completion 2026-06-22 (estimated)
Updated on ClinicalTrials.gov 2026-07-09